{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T18:38:02Z","timestamp":1787855882603,"version":"build-2784847793"},"reference-count":67,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 GM104941"],"award-info":[{"award-number":["U54 GM104941"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 LM012527"],"award-info":[{"award-number":["R01 LM012527"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1650851"],"award-info":[{"award-number":["1650851"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cjcopen.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CJC Open"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.cjco.2021.01.016","type":"journal-article","created":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:58:52Z","timestamp":1612573132000},"page":"801-813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Machine Learning Methods for Identifying Atrial Fibrillation Cases and Their Predictors in Patients With Hypertrophic Cardiomyopathy: The HCM-AF-Risk Model"],"prefix":"10.1016","volume":"3","author":[{"given":"Moumita","family":"Bhattacharya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai-Yin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Ventoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela V.","family":"Greenland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hulya","family":"Yalcin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufan","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Marine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey E.","family":"Olgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan L.","family":"Zimmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore P.","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Roselle","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagit","family":"Shatkay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjco.2021.01.016_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.15420\/aer.2017:4:2","article-title":"Atrial fibrillation and anticoagulation in hypertrophic cardiomyopathy","volume":"6","author":"Camm","year":"2017","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"10.1016\/j.cjco.2021.01.016_bib2","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/hc4601.097997","article-title":"Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy","volume":"104","author":"Olivotto","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2021.01.016_bib3","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.hrthm.2018.11.029","article-title":"Effect of hypertrophic cardiomyopathy on the prediction of thromboembolism in patients with nonvalvular atrial fibrillation","volume":"16","author":"Tsuda","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjco.2021.01.016_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0735-1097(01)01727-2","article-title":"Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy","volume":"39","author":"Maron","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.18962","article-title":"Comparison of machine learning methods with traditional models for use of administrative claims with electronic medical records to predict heart failure outcomes","volume":"3","author":"Desai","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cjco.2021.01.016_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41569-019-0158-5","article-title":"Artificial intelligence to improve the diagnosis of cardiovascular diseases","volume":"16","author":"Fernandez-Ruiz","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib7","doi-asserted-by":"crossref","first-page":"6509357","DOI":"10.1155\/2019\/6509357","article-title":"A\u00a0technical review of convolutional neural network-based mammographic breast cancer diagnosis","volume":"2019","author":"Zou","year":"2019","journal-title":"Comput Math Methods Med"},{"key":"10.1016\/j.cjco.2021.01.016_bib8","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.artmed.2019.01.006","article-title":"A\u00a0survey of neural network-based cancer prediction models from microarray data","volume":"97","author":"Daoud","year":"2019","journal-title":"Artif Intell Med"},{"key":"10.1016\/j.cjco.2021.01.016_bib9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ahj.2019.10.004","article-title":"Sex-specific cardiac phenotype and clinical outcomes in patients with hypertrophic cardiomyopathy","volume":"219","author":"Lu","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjco.2021.01.016_bib10","first-page":"e783","article-title":"2011 ACCF\/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2021.01.016_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.15420\/aer.2013.2.1.36","article-title":"Mimics of hypertrophic cardiomyopathy\u2014diagnostic clues to aid early identification of phenocopies","volume":"2","author":"Sankaranarayanan","year":"2013","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"10.1016\/j.cjco.2021.01.016_bib12","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/CIR.0000000000000040","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2021.01.016_bib13","first-page":"e199","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2021.01.016_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cjco.2021.01.016_bib15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.amjcard.2017.05.039","article-title":"Role of global longitudinal strain in predicting outcomes in hypertrophic cardiomyopathy","volume":"120","author":"Liu","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/CIRCIMAGING.112.000110","article-title":"Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy","volume":"6","author":"Bravo","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cjco.2021.01.016_bib17","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.amjcard.2016.08.085","article-title":"Effect of diffuse subendocardial hypoperfusion on left ventricular cavity size by (13)N-ammonia perfusion PET in patients with hypertrophic cardiomyopathy","volume":"118","author":"Yalcin","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib18","series-title":"Machine Learning: A Probabilistic Perspective","author":"Murphy","year":"2012"},{"key":"10.1016\/j.cjco.2021.01.016_bib19","series-title":"Introduction to Biostatistics","author":"Sokal","year":"1987"},{"key":"10.1016\/j.cjco.2021.01.016_bib20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/biomet\/29.3-4.350","article-title":"The significance of the difference between two means when the population variances are unequal","volume":"29","author":"Welch","year":"1938","journal-title":"Biometrika"},{"key":"10.1016\/j.cjco.2021.01.016_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2019.07.001","article-title":"Guidelines for performance, interpretation, and application of stress echocardiography in ischemic heart disease: from the American Society of Echocardiography","volume":"33","author":"Pellikka","year":"2020","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cjco.2021.01.016_bib22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/BF02296207","article-title":"Maximum likelihood estimation of the polychoric correlation coefficient","volume":"44","author":"Olsson","year":"1979","journal-title":"Psychometrika"},{"key":"10.1016\/j.cjco.2021.01.016_bib23","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.amjcard.2019.02.022","article-title":"Identifying ventricular arrhythmias and their predictors by applying machine learning methods to electronic health records in patients with hypertrophic cardiomyopathy (HCM-VAr-Risk Model)","volume":"123","author":"Bhattacharya","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib24","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(09)60443-8","article-title":"Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study","volume":"373","author":"Schnabel","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cjco.2021.01.016_bib25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.amjcard.2010.08.049","article-title":"A\u00a0clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study)","volume":"107","author":"Chamberlain","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib26","article-title":"Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium","volume":"2","author":"Alonso","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjco.2021.01.016_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004052","article-title":"Left atrial size and function in hypertrophic cardiomyopathy patients and risk of new-onset atrial fibrillation","volume":"10","author":"Debonnaire","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/heartjnl-2013-304276","article-title":"Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review","volume":"100","author":"Guttmann","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.cjco.2021.01.016_bib29","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.amjcard.2013.12.045","article-title":"Left atrial remodeling in hypertrophic cardiomyopathy and susceptibility markers for atrial fibrillation identified by cardiovascular magnetic resonance","volume":"113","author":"Maron","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib30","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.acvd.2018.03.007","article-title":"Predictors of future onset of atrial fibrillation in hypertrophic cardiomyopathy","volume":"111","author":"Cochet","year":"2018","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.cjco.2021.01.016_bib31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/echo.13093","article-title":"Predictors of future atrial fibrillation development in patients with hypertrophic cardiomyopathy: a prospective follow-up study","volume":"33","author":"Tuluce","year":"2016","journal-title":"Echocardiography"},{"key":"10.1016\/j.cjco.2021.01.016_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.amjcard.2019.09.032","article-title":"Evaluation of risk prediction models of atrial fibrillation (from the Multi-Ethnic Study of Atherosclerosis [MESA])","volume":"125","author":"Bundy","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib33","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/aje\/kwk115","article-title":"Age, gene\/environment susceptibility-Reykjavik Study: multidisciplinary applied phenomics","volume":"165","author":"Harris","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib34","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s10654-017-0321-4","article-title":"The Rotterdam Study: 2018 update on objectives, design and main results","volume":"32","author":"Ikram","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib35","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1093\/eurheartj\/ehy404","article-title":"Clinical applications of machine learning in cardiovascular disease and its relevance to cardiac imaging","volume":"40","author":"Al'Aref","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2021.01.016_bib36","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1097\/HJH.0000000000002075","article-title":"Coronary heart disease diagnosis by artificial neural networks including aortic pulse wave velocity index and clinical parameters","volume":"37","author":"Vallee","year":"2019","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.cjco.2021.01.016_bib37","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0735-1097(02)02373-2","article-title":"Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women","volume":"40","author":"Tsang","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib38","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1161\/CIRCULATIONAHA.109.873265","article-title":"N-terminal pro-B-type natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study","volume":"120","author":"Patton","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2021.01.016_bib39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0079-6107(03)00012-9","article-title":"The role of atrial dilatation in the domestication of atrial fibrillation","volume":"82","author":"Schotten","year":"2003","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.cjco.2021.01.016_bib40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.amjcard.2003.09.012","article-title":"Risks for atrial fibrillation and congestive heart failure in patients > \/\u00a0= 65 years of age with abnormal left ventricular diastolic relaxation","volume":"93","author":"Tsang","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib41","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/eurheartj\/ehr378","article-title":"Echocardiographic diastolic parameters and risk of atrial fibrillation: the Cardiovascular Health Study","volume":"33","author":"Rosenberg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2021.01.016_bib42","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.echo.2004.02.010","article-title":"Left atrial volume and the risk of paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"17","author":"Tani","year":"2004","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cjco.2021.01.016_bib43","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.amjcard.2014.01.435","article-title":"Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors","volume":"113","author":"Spirito","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib44","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.echo.2009.09.016","article-title":"Left atrial volume index: a predictor of adverse outcome in patients with hypertrophic cardiomyopathy","volume":"22","author":"Yang","year":"2009","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cjco.2021.01.016_bib45","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000354953","article-title":"Clinical profile and prognostic significance of atrial fibrillation in hypertrophic cardiomyopathy","volume":"126","author":"Tian","year":"2013","journal-title":"Cardiology"},{"key":"10.1016\/j.cjco.2021.01.016_bib46","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.amjcard.2004.06.024","article-title":"Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy","volume":"94","author":"Losi","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib47","first-page":"3250","article-title":"Atrial fibrillation in heart failure: What should we do?","volume":"36","author":"Kotecha","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjco.2021.01.016_bib48","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/01.CIR.99.2.254","article-title":"Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy","volume":"99","author":"Nagueh","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2021.01.016_bib49","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1161\/CIRCULATIONAHA.112.113233","article-title":"Diastolic dysfunction and risk of atrial fibrillation: a mechanistic appraisal","volume":"126","author":"Rosenberg","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2021.01.016_bib50","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/ejechocard\/jeq024","article-title":"Diastolic dysfunction predicts new-onset atrial fibrillation and cardiovascular events in patients with acute myocardial infarction and depressed left ventricular systolic function: a CARISMA substudy","volume":"11","author":"Jons","year":"2010","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.cjco.2021.01.016_bib51","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1016\/j.ejrad.2009.12.012","article-title":"Correlation between myocardial fibrosis and the occurrence of atrial fibrillation in hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study","volume":"75","author":"Pujadas","year":"2010","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib52","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1054-8807(01)00086-2","article-title":"Does the progression of myocardial fibrosis lead to atrial fibrillation in patients with hypertrophic cardiomyopathy?","volume":"10","author":"Yamaji","year":"2001","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.cjco.2021.01.016_bib53","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1532-429X-11-34","article-title":"CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation","volume":"11","author":"Papavassiliu","year":"2009","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.cjco.2021.01.016_bib54","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jacep.2018.10.016","article-title":"Hypertrophic cardiomyopathy patients with paroxysmal atrial fibrillation have a high burden of left atrial fibrosis by cardiac magnetic resonance imaging","volume":"5","author":"Sivalokanathan","year":"2019","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib55","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/heartjnl-2013-304908","article-title":"Exercise capacity and paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"100","author":"Azarbal","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.cjco.2021.01.016_bib56","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.echo.2019.01.007","article-title":"Low left atrial strain is associated with adverse outcomes in hypertrophic cardiomyopathy patients","volume":"32","author":"Vasquez","year":"2019","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.cjco.2021.01.016_bib57","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/ejhf.959","article-title":"Atrial fibrillation modifies the association between pulmonary artery wedge pressure and left ventricular end-diastolic pressure","volume":"19","author":"Dickinson","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjco.2021.01.016_bib58","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.amjcard.2015.01.548","article-title":"Exercise heart rates in patients with hypertrophic cardiomyopathy","volume":"115","author":"Luo","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib59","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/CIRCULATIONAHA.112.136085","article-title":"Risk stratification and outcome of patients with hypertrophic cardiomyopathy >\u00a0= 60 years of age","volume":"127","author":"Maron","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.cjco.2021.01.016_bib60","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2967\/jnumed.111.096156","article-title":"PET\/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy","volume":"53","author":"Bravo","year":"2012","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cjco.2021.01.016_bib61","first-page":"201","article-title":"Diffuse interstitial fibrosis assessed by cardiac magnetic resonance is associated with dispersion of ventricular repolarization in patients with hypertrophic cardiomyopathy","volume":"33","author":"Hurtado-de-Mendoza","year":"2017","journal-title":"J\u00a0Arrhythm"},{"key":"10.1016\/j.cjco.2021.01.016_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2013.06.011","article-title":"Association between septal strain rate and histopathology in symptomatic hypertrophic cardiomyopathy patients undergoing septal myectomy","volume":"166","author":"Kobayashi","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjco.2021.01.016_bib63","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/0002-9149(87)90406-1","article-title":"Relation between extent of left ventricular hypertrophy and occurrence of ventricular tachycardia in hypertrophic cardiomyopathy","volume":"60","author":"Spirito","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib64","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.amjcard.2013.06.018","article-title":"Prognostic value of N-terminal pro-brain natriuretic peptide in outpatients with hypertrophic cardiomyopathy","volume":"112","author":"D'Amato","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9149(99)00251-9","article-title":"Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation","volume":"83","author":"Gruver","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjco.2021.01.016_bib66","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s100380200021","article-title":"Relation between angiotensin-converting enzyme II genotype and atrial fibrillation in Japanese patients with hypertrophic cardiomyopathy","volume":"47","author":"Ogimoto","year":"2002","journal-title":"J\u00a0Hum Genet"},{"key":"10.1016\/j.cjco.2021.01.016_bib67","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.amjcard.2015.12.058","article-title":"Impact of genotype on the occurrence of atrial fibrillation in patients with hypertrophic cardiomyopathy","volume":"117","author":"Bongini","year":"2016","journal-title":"Am J Cardiol"}],"container-title":["CJC Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X21000317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589790X21000317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:14:32Z","timestamp":1778904872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589790X21000317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2589790X21000317"],"URL":"https:\/\/doi.org\/10.1016\/j.cjco.2021.01.016","relation":{"has-preprint":[{"id-type":"doi","id":"10.22541\/au.159682206.69766798","asserted-by":"object"}]},"ISSN":["2589-790X"],"issn-type":[{"value":"2589-790X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Machine Learning Methods for Identifying Atrial Fibrillation Cases and Their Predictors in Patients With Hypertrophic Cardiomyopathy: The HCM-AF-Risk Model","name":"articletitle","label":"Article Title"},{"value":"CJC Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjco.2021.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}